about
Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice.Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunctionHyperlipidemia, tissue factor, coagulation, and simvastatinThe bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in miceMembrane curvature recognition by C-reactive protein using lipoprotein mimics.Scavenger receptor structure and function in health and disease.Beta2 integrins modulate the initiation and progression of atherosclerosis in low-density lipoprotein receptor knockout mice.Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.Oxidized LDL: diversity, patterns of recognition, and pathophysiology.Impact of hydrophobic chain composition on amphiphilic macromolecule antiatherogenic bioactivityNMR spectroscopy of macrophages loaded with native, oxidized or enzymatically degraded lipoproteins.Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet.Lack of association between glutathione peroxidase1 (GPx1) activity, Pro198Leu polymorphism and stenosis of coronary arteries: A population-based prediction.Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretionDiabetes and alpha lipoic Acid.Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosisA practical approach to using mice in atherosclerosis research.Cysteine Protease Cathepsins in Atherosclerosis and Abdominal Aortic Aneurysm.The Impact of HIV Coinfection on Cerebral Malaria Pathogenesis.Highly upregulated expression of CD36 and MSR1 in circulating monocytes of patients with acute coronary syndromesComparative study of extrapolative factors linked with oxidative injury and anti-inflammatory status in chronic kidney disease patients experiencing cardiovascular distressAnti-oxidized low-density lipoprotein antibodies in chronic heart failure.YC-1 induces lipid droplet formation in RAW 264.7 macrophages.Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques.Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.Micellar and structural stability of nanoscale amphiphilic polymers: Implications for anti-atherosclerotic bioactivity.CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction.Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.MnSOD and GPx1 polymorphism relationship with coronary heart disease risk and severity.Cholesterol in platelet biogenesis and activation.Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity.Regulation of atherosclerosis and associated risk factors by adenosine and adenosine receptors.Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases.Novel Mechanistic Interplay between Products of Oxidative Stress and Components of the Complement System in AMD PathogenesisApolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.The LDL modification hypothesis of atherogenesis: an update.Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake.Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism.Overexpression of NF-κB p65 in macrophages ameliorates atherosclerosis in apoE-knockout miceDevelopmental onset of bilirubin-induced neurotoxicity involves Toll-like receptor 2-dependent signaling in humanized UDP-glucuronosyltransferase1 mice.
P2860
Q24805374-F3F29546-5EA8-4C5A-B877-2E0E4DBCC16CQ26830607-4AB791BB-E99F-4596-B0DA-E233530BFDB8Q27024964-B6DFD49F-2F6C-45ED-9DF7-D96800E69B84Q27318414-CCCE4F28-E8CC-4FC9-BB97-DBC5D08F2DE2Q30544305-B4ABA3DD-7F62-4462-82F7-886080738EEAQ30958610-63647E19-43A7-471C-BF7E-99D34BAADE03Q33644481-BBD50410-78E4-4747-B410-EE9D0420D7DEQ33675617-AD5AAF3A-ABA9-4B3F-8122-2D3C0F60E6A3Q33879138-ADB1A2FA-0600-4FF7-A65D-95D982B0AFBCQ34149692-746E8F7F-6215-44B7-B9A1-A8DD1C8E1B9CQ34606755-003D54BF-0880-47F8-BB3A-460A17C5EE92Q34763602-819B7D5F-5236-4396-A47C-C0B57B14F422Q34878951-EE974019-F900-4EC5-BCDE-700052B2F2AAQ35097354-46F818DE-F7C1-4D31-95DC-3387FA10A9FCQ35564911-BF18B548-8E86-41FE-90EE-8A6A8359AF56Q35710262-62DDE280-F0D3-46AD-9090-B90DECFF2FAAQ35754358-CF63A0B8-EB94-4A0F-B1E3-23766970FDBAQ35883165-D9275DAE-4E65-486E-A96B-DAA4733D5523Q35912396-6D5BCB2F-9D30-4BB1-928D-589C244ACBBEQ36095925-E2EC0B3E-C32B-4769-A120-28B227D8654DQ36274244-32168F5E-8917-4426-8014-8BB7AA9595E7Q36421852-C575AD94-D239-4DD5-AFA7-745DA8E9287BQ36466801-F6514AE3-4E30-465B-8FBD-FE12CBD20935Q36496336-B33BE5E5-6007-4522-AB97-CD03D3B73C34Q36524275-E3F64D7F-FDE7-4313-A0C9-19240FA90BE0Q36586338-29B4F947-4EB3-428C-A37E-63412612E068Q36711861-2E0FC04E-EFF3-4EBB-A4CA-927939EA81C3Q36723319-BCE5F831-FA87-49EF-BF8D-84EB1107645BQ36790505-DCA62BEE-1272-44CA-9559-4ECA8C076A54Q36825794-AF3055A4-0906-4AAC-A98F-26F97810F158Q37088740-B47F4096-DCB6-408A-9E6C-A0DE2458E786Q37137878-75C158AA-A6F0-4CBB-8012-91258BCE0690Q37275036-66F0AF80-9E55-4257-8EF0-AA1C9E736B5DQ37280091-8965F2DB-C1A4-447C-BD4F-D3B2C0BDB772Q37286296-A902807A-E070-4554-BDF3-EAA4043D521AQ37326175-DAF1A4E5-B02D-4448-B0F5-135A829DF5A5Q37340933-4144FD9C-414D-4799-82EE-170FD59C2859Q37360635-B37D5FB8-72DF-48DB-9B38-A45694FA7113Q37439775-FEFD63CE-C77C-4091-8A24-C5E3A3120745Q37596306-DF6FA52B-4A1D-449A-A2E2-93B49AF6011C
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Scavenger receptors, oxidized LDL, and atherosclerosis.
@ast
Scavenger receptors, oxidized LDL, and atherosclerosis.
@en
Scavenger receptors, oxidized LDL, and atherosclerosis.
@nl
type
label
Scavenger receptors, oxidized LDL, and atherosclerosis.
@ast
Scavenger receptors, oxidized LDL, and atherosclerosis.
@en
Scavenger receptors, oxidized LDL, and atherosclerosis.
@nl
prefLabel
Scavenger receptors, oxidized LDL, and atherosclerosis.
@ast
Scavenger receptors, oxidized LDL, and atherosclerosis.
@en
Scavenger receptors, oxidized LDL, and atherosclerosis.
@nl
P2093
P1476
Scavenger receptors, oxidized LDL, and atherosclerosis.
@en
P2093
Boullier A
Friedman P
Gillotre-Taylor K
Palinski W
Quehenberger O
P304
214-22; discussion 222-3
P407
P577
2001-12-01T00:00:00Z